Are you Dr. Jenkins?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 43 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4200 E 9th Ave
Room 1813 Campus Box B168
Denver, CO 80262Phone+1 303-315-7233Fax+1 303-436-5131- Is this information wrong?
Summary
- Dr. Timothy Jenkins, MD is an infectious disease specialist in Denver, Colorado. He is currently licensed to practice medicine in Colorado. He is affiliated with Denver Health and is an Assistant Professor at University of Colorado School of Medicine.
Education & Training
- University of ColoradoFellowship, Infectious Disease, 2005 - 2008
- University of ColoradoResidency, Internal Medicine, 2002 - 2005
- Johns Hopkins University School of MedicineClass of 2002
Certifications & Licensure
- CO State Medical License 2005 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection Start of enrollment: 2011 Feb 01
- Duration of Antibiotic Treatment for Early VAP (DATE) Trial Start of enrollment: 2013 Dec 01
Publications & Presentations
PubMed
- Associations with unplanned repeat irrigation and debridement of native septic arthritis.Benjamin D Pesante, Maryam Salimi, Whitney L Miller, Heather L Young, Timothy C Jenkins, Joshua A Parry> ;European Journal of Orthopaedic Surgery & Traumatology. 2024 Apr 4
- Clinical Outcomes Associated with Amoxicillin Treatment for Acute Otitis Media in Children.Holly M Frost, Amy Keith, Dana R Fletcher, Thresia Sebastian, Samuel R Dominguez, Melanie Kurtz, Sarah K Parker, Michael L Wilson, Timothy C Jenkins> ;Journal of the Pediatric Infectious Diseases Society. 2024 Mar 19
- Interventions to de-implement unnecessary antibiotic prescribing for ear infections (DISAPEAR Trial): protocol for a cluster-randomized trial.Keith, A., Stein, A., Eggleston, A., Rinehart, D., Walter, E., Hargraves, I., Frost, H., , Jenkins, T., Hersh, A., Narayan, R., Patel, P.> ;BMC Infectious Diseases. 2024 Jan 24
- Join now to see all
Press Mentions
- Decreased Antibiotic Utilization After Implementation of a Guideline for Inpatient Cellulitis and Cutaneous AbscessOctober 20th, 2016
- Women Willing to Delay Antibiotics for UTIsJune 3rd, 2013
- Champions for Their Patients: 21 Inducted into CU Department of Medicine’s New Clinical Excellence SocietyFebruary 29th, 2024
Hospital Affiliations
- Denver HealthDenver, Colorado